The reduction rate of serum C3 following liver transplantation is an effective predictor of non-anastomotic strictures

[1]  F. Welch,et al.  Causes and Consequences , 2017, Nature.

[2]  H. Braun,et al.  Biliary complications following living donor hepatectomy. , 2016, Transplantation reviews.

[3]  D. Seehofer,et al.  Biliary Complications After Liver Transplantation: Old Problems and New Challenges , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  M. Neuenhahn,et al.  A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3 , 2011, Nature Immunology.

[5]  V. Frémeaux-Bacchi,et al.  Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. , 2011, Blood.

[6]  M. Goddard,et al.  Targeted Complement Inhibitors Protect against Posttransplant Cardiac Ischemia and Reperfusion Injury and Reveal an Important Role for the Alternative Pathway of Complement Activation , 2010, The Journal of Immunology.

[7]  U. Neumann,et al.  Incidence of and risk factors for ischemic‐type biliary lesions following orthotopic liver transplantation , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  K. Cianflone,et al.  A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. , 2009, The Journal of clinical investigation.

[9]  T. V. van Gulik,et al.  Complement-Mediated Ischemia-Reperfusion Injury: Lessons Learned From Animal and Clinical Studies , 2009, Annals of surgery.

[10]  C. Atkinson,et al.  A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury1 , 2008, The Journal of Immunology.

[11]  John D Lambris,et al.  Complexity of complement activation in sepsis , 2008, Journal of cellular and molecular medicine.

[12]  T. Welling,et al.  Biliary complications following liver transplantation in the model for end‐stage liver disease era: Effect of donor, recipient, and technical factors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  E. J. van der Jagt,et al.  Anastomotic biliary strictures after liver transplantation: Causes and consequences , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  J. Thurman,et al.  The Central Role of the Alternative Complement Pathway in Human Disease1 , 2006, The Journal of Immunology.

[15]  C. Hack,et al.  Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model , 2006, Clinical and experimental immunology.

[16]  P. Neuhaus,et al.  Bile duct complications after liver transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[17]  T. Mollnes,et al.  Complement C5a Is a Key Mediator of Meconium-Induced Neutrophil Activation , 2005, Pediatric Research.

[18]  S. Wigmore,et al.  Management of biliary tract complications after orthotopic liver transplantation , 2004, Clinical transplantation.

[19]  J. Benson,et al.  Risk Factors for and Clinical Course of Non‐Anastomotic Biliary Strictures After Liver Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  L. Halme,et al.  Cytomegalovirus infection and development of biliary complications after liver transplantation1 , 2003, Transplantation.

[21]  J. Thurman,et al.  Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice 1 , 2003, The Journal of Immunology.

[22]  L. Grande,et al.  Intrahepatic biliary lesions after orthotopic liver transplantation , 2001, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  D. V. van Thiel,et al.  Ischemia‐reperfusion injury in rat fatty liver: Role of nutritional status , 1999, Hepatology.

[24]  C. Degott,et al.  Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance. , 1997, Gastroenterology.

[25]  K. D. de Jong,et al.  Biliary reconstruction during liver transplantation in patients with primary sclerosing cholangitis. , 1997, Transplantation proceedings.

[26]  M. Kaplan,et al.  Extrahepatic biliary stricture associated with cytomegalovirus in a liver transplant recipient , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[27]  L. Matis,et al.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. , 1995, The Journal of clinical investigation.

[28]  B. Morgan.  Complement regulatory molecules: application to therapy and transplantation. , 1995, Immunology today.

[29]  S. Cohn,et al.  A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation , 1995, Hepatology.

[30]  G. Gores,et al.  Diagnostic features and clinical outcome of ischemic‐type biliary complications after liver transplantation , 1993, Hepatology.

[31]  R. Stratta,et al.  Diffuse biliary tract injury after orthotopic liver transplantation. , 1992, American journal of surgery.

[32]  R. Busuttil,et al.  Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. , 1992, Annals of surgery.

[33]  E. Vonesh,et al.  Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.

[34]  P. Sims,et al.  The response of human platelets to activated components of the complement system. , 1991, Immunology today.

[35]  H. Jaeschke,et al.  Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. , 1991, The American journal of physiology.

[36]  D. Samuel,et al.  Liver transplantation across ABO blood group barriers , 1990, The Lancet.

[37]  T. Starzl,et al.  Orthotopic homotransplantation of the human liver. , 1968 .

[38]  C. Buis.  Molecular and biochemical mechanisms of bile duct injury after liver transplantation , 2008 .

[39]  B. Markus,et al.  Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. , 1988, The American journal of pathology.